Hemoclip
Hangzhou AGS MedTech Co., Ltd. · Decision date Apr 8, 2026
What did the FDA decide?
FDA records K252270 as a 510(k) premarket notification, with a decision dated Apr 8, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Apr 8, 2026
Regulatory record facts
- Identifier
- K252270
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Hangzhou AGS MedTech Co., Ltd.
- Product code
- PKL
- Decision code
- SESE
- Decision date
- Apr 8, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Hemostatic Metal Clip For The Gi Tract.
- Applicant
- Hangzhou AGS MedTech Co., Ltd.
- Product code
- PKL
- FDA device class
- 2
FDA decision timeline
K252270 received
Application receipt date recorded by FDA.
K252270 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code PKL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Ovesco Endoscopy AG | 510(k) clearance | Oct 2, 2026 | FDA | |
Hemostatic ClipK261741 | Anrei Medical (Hz) Co., Ltd. | 510(k) clearance | Oct 2, 2026 | FDA |
| Ovesco Endoscopy AG | 510(k) clearance | Sep 14, 2026 | FDA | |
| Hangzhou AGS MedTech Co., Ltd. | 510(k) clearance | Aug 10, 2026 | FDA | |
| Olympus Medical Systems Corp. | 510(k) clearance | May 21, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Hangzhou AGS MedTech Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Hangzhou
Sources and methodology
- Original FDA record: K252270
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



